Use of 5′-methylthioadenosine (MTA) in the prevention and/or treatment of autoimmune diseases and/or transplant rejection

Assignee

• Proyecto De Biomedicina Cima, S.L.

Inventors

• Pablo Villoslada Díaz (2 patents)
• Matías Ávila Zaragoza (1 patents)
• Unknown
• Fernando Corrales Izquierdo (2 patents)
• Carmen Berasain Lasarte (1 patents)
• Elena Ruiz García-Trevijano (1 patents)

View full patent text on Google Patents →